FOREST LABORATORIES, INC.

Inactive Instrument

Forest Laboratories, Inc. Stock

Stocks

US3458381064

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

07/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE

Latest news: Forest Laboratories, Inc.

07/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
14/04/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
11/04/14	Icahn backs down from demand that eBay spin off PayPal	RE
21/02/14	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/02/14	Icahn says Actavis-Forest deal validates shareholder activism	RE
19/02/14	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
19/02/14	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
09/01/14	S&P 500 ends flat in wake of Fed minutes	RE
08/01/14	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/01/14	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
24/10/13	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

Press Releases: Forest Laboratories, Inc.

01/07/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
24/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
21/06/14	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

More press releases

News in other languages: Forest Laboratories, Inc.

18/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/04/14	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	-0.65%	-2.93%	+47.70%	+86.30%	994B
	JOHNSON & JOHNSON	-0.29%	-3.51%	+49.15%	+61.95%	640B
	ABBVIE INC.	+0.83%	+0.26%	+17.76%	+70.10%	454B
	ROCHE HOLDING AG	+4.26%	+1.47%	+37.79%	+38.24%	337B
	NOVARTIS AG	+2.59%	-8.58%	+17.45%	+25.73%	261B
	ASTRAZENECA PLC	+2.39%	-0.43%	+5.05%	+10.87%	246B
	AMGEN INC.	-1.34%	-13.70%	+36.53%	+46.70%	204B
	NOVO NORDISK A/S	+1.75%	-5.97%	-20.84%	-58.84%	190B
	GILEAD SCIENCES, INC.	-0.75%	-4.82%	+25.46%	+85.90%	178B
	Average	+0.95%	-5.76%	+24.01%	+40.77%	389.42B
	Weighted average by Cap.	+0.60%	-4.42%	+32.39%	+55.14%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!